Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1976 2
1977 2
1978 2
1979 2
1980 1
1981 2
1982 4
1983 2
1984 6
1985 4
1986 5
1987 7
1988 8
1989 4
1990 6
1991 3
1992 6
1993 13
1994 4
1995 14
1996 17
1997 11
1998 22
1999 19
2000 18
2001 22
2002 14
2003 21
2004 16
2005 22
2006 12
2007 24
2008 13
2009 18
2010 11
2011 13
2012 14
2013 16
2014 18
2015 26
2016 16
2017 12
2018 11
2019 14
2020 12
2021 10
2022 14
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

510 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Pituitary hormone deficiency, combined, 2"
Page 1
Hypothyroidism: etiology, diagnosis, and management.
Almandoz JP, Gharib H. Almandoz JP, et al. Med Clin North Am. 2012 Mar;96(2):203-21. doi: 10.1016/j.mcna.2012.01.005. Epub 2012 Feb 14. Med Clin North Am. 2012. PMID: 22443971 Review.
Hypothyroidism is the result of inadequate production of thyroid hormone or inadequate action of thyroid hormone in target tissues. Primary hypothyroidism is the principal manifestation of hypothyroidism, but other causes include central deficiency of thyrotr …
Hypothyroidism is the result of inadequate production of thyroid hormone or inadequate action of thyroid hormone in target tis …
Should Skeletal Maturation Be Manipulated for Extra Height Gain?
Wit JM. Wit JM. Front Endocrinol (Lausanne). 2021 Dec 16;12:812196. doi: 10.3389/fendo.2021.812196. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34975773 Free PMC article. Review.
If rhGH-treated children with growth hormone deficiency or those who were born small-for-gestational age are still short at pubertal onset, co-treatment with a GnRHa for 2-3 years increases AH. ...Administration of letrozole to boys with constitutional delay …
If rhGH-treated children with growth hormone deficiency or those who were born small-for-gestational age are still short at pu …
Overt and subclinical hypothyroidism: who to treat and how.
Khandelwal D, Tandon N. Khandelwal D, et al. Drugs. 2012 Jan 1;72(1):17-33. doi: 10.2165/11598070-000000000-00000. Drugs. 2012. PMID: 22191793 Review.
Hypothyroidism denotes deficient production of thyroid hormone by the thyroid gland and can be primary (abnormality in thyroid gland itself) or secondary/central (as a result of hypothalamic or pituitary disease). ...Limited evidence suggests that treatment o …
Hypothyroidism denotes deficient production of thyroid hormone by the thyroid gland and can be primary (abnormality in thyroid …
Hypopituitarism.
Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, Stalla GK, Ghigo E. Schneider HJ, et al. Lancet. 2007 Apr 28;369(9571):1461-1470. doi: 10.1016/S0140-6736(07)60673-4. Lancet. 2007. PMID: 17467517 Review.
Incidence and prevalence of hypopituitarism are estimated to be 4.2 per 100,000 per year and 45.5 per 100,000, respectively. Although the clinical symptoms of this disorder are usually unspecific, it can cause life-threatening events and lead to increased mortality. …
Incidence and prevalence of hypopituitarism are estimated to be 4.2 per 100,000 per year and 45.5 per 100,000, respectively. Although …
Lutropin alfa.
Dhillon S, Keating GM. Dhillon S, et al. Drugs. 2008;68(11):1529-40. doi: 10.2165/00003495-200868110-00005. Drugs. 2008. PMID: 18627209 Review.
Dose-finding studies revealed a significant dose-dependent increase in the rate of optimal follicular development among women with hypogonadotropic hypogonadism and profound LH deficiency (<1.2 IU/L) who received subcutaneous lutropin alfa 0-225 IU/day plus folli …
Dose-finding studies revealed a significant dose-dependent increase in the rate of optimal follicular development among women with hypogonad …
Amiodarone and thyroid.
Eskes SA, Wiersinga WM. Eskes SA, et al. Best Pract Res Clin Endocrinol Metab. 2009 Dec;23(6):735-51. doi: 10.1016/j.beem.2009.07.001. Best Pract Res Clin Endocrinol Metab. 2009. PMID: 19942150 Review.
AM-induced thyrotoxicosis (AIT) occurs at any time during treatment, preferentially in iodine-deficient regions and in males. AIT can be classified in type 1 (iodide-induced thyrotoxicosis, best treated by potassium perchlorate in combination with thionamides and di …
AM-induced thyrotoxicosis (AIT) occurs at any time during treatment, preferentially in iodine-deficient regions and in males. AIT can …
Testosterone deficiency in men with Type 2 diabetes: pathophysiology and treatment.
Gianatti EJ, Grossmann M. Gianatti EJ, et al. Diabet Med. 2020 Feb;37(2):174-186. doi: 10.1111/dme.13977. Epub 2019 Jun 4. Diabet Med. 2020. PMID: 31006133 Review.
In men with diabetes, testosterone treatment effects on androgen deficiency-like clinical features are inconsistent, and effects on sexual dysfunction may be attenuated compared with men without diabetes. ...Although large, well-designed clinical trials are n …
In men with diabetes, testosterone treatment effects on androgen deficiency-like clinical features are inconsistent, and effec …
Von Willebrand's disease.
Ewenstein BM. Ewenstein BM. Annu Rev Med. 1997;48:525-42. doi: 10.1146/annurev.med.48.1.525. Annu Rev Med. 1997. PMID: 9046981 Review.
The current classification distinguishes disorders arising from partial (type 1) or complete (type 3) deficiencies and from qualitative defects (type 2). Type 2 vWD is further divided into four subtypes (A, B, N, and M), reflecting distinct classes of functio …
The current classification distinguishes disorders arising from partial (type 1) or complete (type 3) deficiencies and from qualitati …
Long-term safety of growth hormone-A combined registry analysis.
Stochholm K, Kiess W. Stochholm K, et al. Clin Endocrinol (Oxf). 2018 Apr;88(4):515-528. doi: 10.1111/cen.13502. Epub 2017 Nov 20. Clin Endocrinol (Oxf). 2018. PMID: 29055168 Review.
OBJECTIVES: Preliminary data from the French cohort of the Safety and Appropriateness of Growth hormone treatments in Europe (SAGhE) study raised concerns regarding the safety of recombinant human GH, suggesting that GH may increase mortality and incidence of stroke in pat …
OBJECTIVES: Preliminary data from the French cohort of the Safety and Appropriateness of Growth hormone treatments in Europe (SAGhE) …
Human pituitary growth hormone (hGH) therapy in growth hormone deficiency.
Frasier SD. Frasier SD. Endocr Rev. 1983 Spring;4(2):155-70. doi: 10.1210/edrv-4-2-155. Endocr Rev. 1983. PMID: 6345147 Review.
This review has attempted to answer a number of questions regarding human growth hormone therapy in growth hormone deficiency. I believe that the available data support several conclusions which form a suggested current approach to the clinical use of …
This review has attempted to answer a number of questions regarding human growth hormone therapy in growth hormone deficien …
510 results